John J. Byrnes, M.D.
General Information

Appointments
Contact:
- Fax: 305-243-9161
Specialties
- Internal Medicine
- Hematology/Oncology - Internal Medicine
Languages
English
Clinical Areas
Benign Hematology
Leukemia, Multiple Myeloma and Related Blood Cancer
Lymphoma, CLL/SLL, Leukemia (Hairy Cell)
SCT ( Stem Cell Transplant)
Certifications
- American Bd of Internal Med-Diagnostic Laboratory Immunol
- American Board of Internal Medicine
- American Board of Internal Med-Hematology
- American Board of Internal Med-Medical Oncology
Roles
- Professor of Medicine
Research Interests
Mechanism and treatment of thrombotic microangiopathy syndromes, including thrombocytic thrombocytopenia purpura (TTP) and hemolytic-uremic syndrome (HUS)
Publications
- Warsch,S and Byrnes,J. Emerging causes of iron deficiency anemia refractory to iron supplementation. World Journal of Gastroenterology. Accepted for publication
- Hare, J M, et al. Byrnes J, et al. Heldman AW. Comparison of Allogenic vs. Autologous Bone Marrow Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients with Ischemic Cardiomyopathy . JAMA 2012 Nov 6:: 1-11
- Trachtenberg B, et al…Byrnes J, Zambrano J, Heldman A, Hare J. Rational and design of the Transendocardial Injection or Autologous Human Cells )bone marrow or mesenchymal) in Chronic Left Ventricular Dysfunctional and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: a randomized, double–blinded, placebo controlled study of safety and efficacy. American Heart Journal, 2011; 161 (3):487-93
- Escalon MP, Stefanovic A, Venkatraman A, Pereira D, Santos ES, Goodman M, Byrnes JJ, Fernandez, HF. Autologous transplantation for relapsed non-Hodgkin’s lymphoma using intravenous busulfan and cyclophosphamide as a conditioning regimen. Bone Marrow Transplant. 2009; 44 (2):89-96
- Massiri M, Byrne GE, Whitcomb CC, Byrnes JJ Synchronous null-cell anaplastic large cell lymphoma and multiple myeloma Ann Hematol 88:923-925 ,2009